A multicenter, randomized, parallel-arm, placebo-controlled (double-blind), active-controlled (open-label) trial to compare the efficacy and safety of once-weekly lonapegsomatropin with placebo and once-daily somatropin product in adults with growth hormone deficiency

  • Preda, Veronica (Primary Chief Investigator)
  • Champion, Bernard (Associate Investigator)
  • Chapman, Nicola (Clinical Trial Unit Staff)
  • Tan, Pearlyn (Clinical Trial Unit Staff)

Project: Research

Project Details

Short titleTCH-306
AcronymforesiGHt
StatusActive
Effective start/end date3/03/2121/01/26